A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia.

Rosen, P J

A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia. [electronic resource] - Leukemia research Mar 2000 - 183-7 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0145-2126

10.1016/s0145-2126(99)00148-4 doi


Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cytarabine--administration & dosage
Female
Humans
Male
Middle Aged
Mitoxantrone--administration & dosage
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Recurrence
Remission Induction
Treatment Outcome